CN1255114C - 两性霉素b的水性组合物 - Google Patents

两性霉素b的水性组合物 Download PDF

Info

Publication number
CN1255114C
CN1255114C CNB018231632A CN01823163A CN1255114C CN 1255114 C CN1255114 C CN 1255114C CN B018231632 A CNB018231632 A CN B018231632A CN 01823163 A CN01823163 A CN 01823163A CN 1255114 C CN1255114 C CN 1255114C
Authority
CN
China
Prior art keywords
amphotericin
sodium chloride
phospholipid
water
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018231632A
Other languages
English (en)
Chinese (zh)
Other versions
CN1505519A (zh
Inventor
S·派
S·里范卡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bharat Serums and Vaccines Ltd
Original Assignee
Bharat Serums and Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums and Vaccines Ltd filed Critical Bharat Serums and Vaccines Ltd
Publication of CN1505519A publication Critical patent/CN1505519A/zh
Application granted granted Critical
Publication of CN1255114C publication Critical patent/CN1255114C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CNB018231632A 2001-03-01 2001-03-16 两性霉素b的水性组合物 Expired - Fee Related CN1255114C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN217MU2001 IN188924B (enExample) 2001-03-01 2001-03-01
IN217/MUM/2001 2001-03-01

Publications (2)

Publication Number Publication Date
CN1505519A CN1505519A (zh) 2004-06-16
CN1255114C true CN1255114C (zh) 2006-05-10

Family

ID=11097223

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018231632A Expired - Fee Related CN1255114C (zh) 2001-03-01 2001-03-16 两性霉素b的水性组合物

Country Status (23)

Country Link
US (1) US20040137049A1 (enExample)
EP (1) EP1368041B1 (enExample)
JP (1) JP2004523566A (enExample)
KR (1) KR100810067B1 (enExample)
CN (1) CN1255114C (enExample)
AT (1) ATE274913T1 (enExample)
AU (1) AU2001250643B2 (enExample)
BG (1) BG108188A (enExample)
BR (1) BR0116922A (enExample)
CA (1) CA2438847A1 (enExample)
CZ (1) CZ20032264A3 (enExample)
DE (1) DE60105322T2 (enExample)
DK (1) DK1368041T3 (enExample)
EA (1) EA006241B1 (enExample)
ES (1) ES2227172T3 (enExample)
IN (1) IN188924B (enExample)
MX (1) MXPA03007777A (enExample)
NZ (1) NZ528281A (enExample)
PT (1) PT1368041E (enExample)
SK (1) SK10742003A3 (enExample)
WO (1) WO2002069983A1 (enExample)
YU (1) YU75403A (enExample)
ZA (1) ZA200307307B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006069929A (ja) * 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
AU2005283726A1 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
CN100418536C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种用于眼科的抗真菌药物组合物
DK2020990T3 (da) 2006-05-30 2010-12-13 Intarcia Therapeutics Inc Strømningsmodulator med en indre kanal til et todelt osmotisk fremføringssystem
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
WO2011037623A1 (en) 2009-09-28 2011-03-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
KR101629521B1 (ko) * 2010-03-16 2016-06-13 우석대학교 산학협력단 난용성 약물 가용화 및 생체막 투과증진을 위한 알코올성 수상을 내상으로 하는 리포좀, 리포좀 조성물 및 리포좀의 제조방법
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
US9744191B2 (en) 2012-03-19 2017-08-29 Yale University Antimicrobial compositions and methods
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
EP3222324B1 (en) * 2016-03-23 2020-05-13 Wayne State University Valproate as a topical anti-fungal treatment
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
CN108344811A (zh) * 2017-01-24 2018-07-31 北京泰德制药股份有限公司 一种注射用脂质体中有机溶剂残留的检测方法
CN108309955B (zh) * 2018-04-27 2020-06-02 武昌理工学院 一种聚明胶肽结合型紫杉醇纳米颗粒的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
FR2651680B1 (fr) * 1989-09-14 1991-12-27 Medgenix Group Sa Nouveau procede de preparation de microparticules lipidiques.
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JP3956402B2 (ja) * 1996-03-04 2007-08-08 日本油脂株式会社 アンホテリシンｂ運搬体
US6180136B1 (en) * 1998-11-10 2001-01-30 Idexx Laboratories, Inc. Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

Also Published As

Publication number Publication date
SK10742003A3 (sk) 2004-01-08
AU2001250643B2 (en) 2007-03-22
BR0116922A (pt) 2004-04-27
ES2227172T3 (es) 2005-04-01
US20040137049A1 (en) 2004-07-15
ATE274913T1 (de) 2004-09-15
CN1505519A (zh) 2004-06-16
KR100810067B1 (ko) 2008-03-05
MXPA03007777A (es) 2003-12-08
YU75403A (sh) 2006-05-25
EA200300948A1 (ru) 2004-04-29
BG108188A (bg) 2004-09-30
PT1368041E (pt) 2005-01-31
JP2004523566A (ja) 2004-08-05
IN188924B (enExample) 2002-11-23
EP1368041B1 (en) 2004-09-01
WO2002069983A1 (en) 2002-09-12
CZ20032264A3 (cs) 2003-12-17
EA006241B1 (ru) 2005-10-27
DK1368041T3 (da) 2005-01-17
ZA200307307B (en) 2004-04-20
DE60105322T2 (de) 2005-09-15
KR20040018337A (ko) 2004-03-03
DE60105322D1 (de) 2004-10-07
NZ528281A (en) 2006-11-30
EP1368041A1 (en) 2003-12-10
CA2438847A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
CN1255114C (zh) 两性霉素b的水性组合物
CN1245955C (zh) 热保护微粒组合物及其最终蒸汽灭菌的方法
CN1283243C (zh) 新的以紫杉化合物为主要组分的药物组合物
CN1505503A (zh) 亚微米颗粒悬浮液制备方法
CN88100965A (zh) 脂质体组合物及其制备
CN1620283A (zh) 微溶解或难溶解的活性成分的分散体的配制
CN1681478A (zh) 铂聚集体及其制备方法
CN1298296A (zh) 红细胞生成素脂质体分散液
CN1281373A (zh) 含有环糊精和紫杉醇类物质的药物组合物
CN1310648C (zh) 局部纳米颗粒螺甾内酯制剂
JP2007511545A (ja) 安定リポソーム組成物
CN1283235C (zh) 清澈稳定的丙泊酚组合物
CN109568582B (zh) 具有光动治疗活性的竹红菌素磷脂纳米盘、其制备方法及应用
CN1954808A (zh) 高剂量盐酸氨溴索冻干制剂及制备方法
CN1255057A (zh) 含有极难溶于水的活性组分的含水药物组合物
CN1915219A (zh) 稳定化的脂质体
CN1700906A (zh) 稳定的无菌过滤性脂质体包封的紫杉烷和其他抗肿瘤药物
CN1183908C (zh) 一种尼莫地平的注射用药物组合物及其制备方法
CN1706371A (zh) 一种高效的马蔺子素制剂及其制备方法
CN1823732A (zh) 一种多烯紫杉醇自组装前体脂质体及其制备方法
CN1287773C (zh) 一种鸦胆子油软胶囊制剂
CN116439372A (zh) 一种高水溶性叶黄素粉末及其制备方法
CN1939315A (zh) 单唾液酸四己糖神经节苷脂固体脂质纳米粒及其制备方法
NL2036378B1 (en) Preparation of liposomes
CN1518479A (zh) 磷脂制剂的稳定化和终末消毒

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060510

Termination date: 20190316